Atopic Dermatitis

 
Elderly Atopic Dermatitis Cases Up 85% in the US Since 1990, New Study Shows
April 23, 2025

New data also demonstrated mixed sex disparities in elderly atopic dermatitis prevalence.

Global Burden of Atopic Dermatitis in Older Adults Underestimated and Expected to Rise Substantially by 2050
April 21, 2025

The global prevalence of AD in older adults increased by 107% between 1990 and 2021, with a greater burden among women and in high sociodemographic regions.

Closing Thoughts With Patient Cases: Choosing the Right Topical Treatment for Patients With Atopic Dermatitis
April 17, 2025

Panelists discuss how choosing topical treatments requires individualized therapy considering factors such as affected body areas, disease severity, patient age, formulation preferences, and insurance coverage.

Exploring Newer Nonsteroidal Topical Treatments for Atopic Dermatitis: JAK Inhibitors and AhR Agonists
April 17, 2025

Panelists discuss how roflumilast demonstrated good efficacy with 56% to 57% of patients achieving an Investigator’s Global Assessment (IGA) score of 0 or 1 after long-term use, making it effective for maintenance therapy with good tolerability.

Exploring Newer Nonsteroidal Topical Treatments for Atopic Dermatitis: PDE4 Inhibitors
April 17, 2025

Panelists discuss how newer nonsteroidal topical treatments like phosphodiesterase-4 inhibitors (crisaborole and roflumilast), JAK inhibitors (ruxolitinib), and aryl hydrocarbon receptor agonists (tapinarof) are expanding options for atopic dermatitis treatment.

Addressing Risks and Adverse Effects of Long-Term Topical Corticosteroid Use
April 17, 2025

Panelists discuss how long-term use of topical steroids is prevalent with 50% of patients using them 15 to 30 days per month, leading to concerns about adverse effects, including topical steroid withdrawal syndrome.

Addressing Current Topical Management of Atopic Dermatitis in Primary Care
April 17, 2025

Panelists discuss how even mild atopic dermatitis can significantly impact quality of life, with 11% of patients with mild symptoms reporting moderate to large impact on their daily functioning.

Navigating Appropriate Use of Topical Corticosteroids in Atopic Dermatitis Treatment
April 17, 2025

Panelists discuss how topical steroids should be used intermittently with scheduled breaks to prevent adverse effects like skin atrophy, striae, and telangiectasias.

Methods for Determining Atopic Dermatitis Severity in Clinical Practice
April 17, 2025

Panelists discuss how various assessment tools like the IGA, EASI score, and BSA are used to determine the severity of atopic dermatitis and document findings for insurance purposes.

Differences in Atopic Dermatitis Presentation Across Age Groups and Skin Types
April 17, 2025

Panelists discuss how atopic dermatitis (AD) affects approximately 7% of adults, has increased by 3% to 5% over the last 5 years, and impacts different body regions depending on age groups.